利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.015 秒)

    Synthesis of soluble derivatives of sexithiophene and their use as the semiconducting channels in thin-film field-effect transistors
    1.
    发明授权
    Synthesis of soluble derivatives of sexithiophene and their use as the semiconducting channels in thin-film field-effect transistors 有权
    合成噻吩的可溶性衍生物及其在薄膜场效应晶体管中作为半导体通道的应用

    公开(公告)号：US06825358B2

    公开(公告)日：2004-11-30

    申请号：US10057024

    申请日：2002-01-25

    申请人： Ali Afzali-Ardakani ,  Tricia Lynn Breen ,  Cherie Renee Kagan

    发明人： Ali Afzali-Ardakani ,  Tricia Lynn Breen ,  Cherie Renee Kagan

    IPC分类号： C07D40900

    CPC分类号： C07F9/65586 ,  C07D333/24 ,  C07F9/655345 ,  H01L51/0036 ,  H01L51/0068 ,  H01L51/0541 ,  H01L51/0545 ,  H01L51/0558

    摘要： In accordance with the first object of this invention soluble derivatives of sexithiophene in which terminal carbons are substituted with various polar groups such as phosphonic esters, phosphonic acids, phosphonates, carboxylic acids, carboxylates, amines, amides, carbamates, and alcohols, each separated from the terminal thiophene rings by one or more methylene groups, are synthesized. An TFT device in accordance with the second objective of this invention employs films of the above sexithiophene derivatives as the semiconducting component. These organic semiconductors are dissolved in common organic solvents and applied to the surface of a substrate using inexpensive, low-temperature solution-based processing such as spin-coating, dip-coating, drop-casting, or microcontact printing.

    摘要翻译： 根据本发明的第一个目的，其中末端碳被诸如膦酸酯，膦酸，膦酸盐，羧酸，羧酸盐，胺，酰胺，氨基甲酸盐和醇的各种极性基团所取代的噻吩的可溶性衍生物， 由一个或多个亚甲基组成的末端噻吩环。 根据本发明的第二目的的TFT器件使用上述异噻吩衍生物的膜作为半导体元件。 将这些有机半导体溶解在普通有机溶剂中，并使用廉价的低温溶液型加工如旋涂，浸涂，滴涂或微接触印刷，将其溶解于基材表面。

    Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
    4.
    发明授权
    Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride 失效
    6-羟基-3-（4- [2-（哌啶-1-基）乙氧基]苯氧基）-2-（4-甲氧基苯基）苯并[b]噻吩盐酸盐的结晶形式

    公开(公告)号：US06653479B1

    公开(公告)日：2003-11-25

    申请号：US10031326

    申请日：2002-01-10

    申请人： Julie Kay Bush ,  Preston Charles Conrad ,  Merlyn Gerard Flom ,  Wayne Douglas Luke

    发明人： Julie Kay Bush ,  Preston Charles Conrad ,  Merlyn Gerard Flom ,  Wayne Douglas Luke

    IPC分类号： C07D40900

    CPC分类号： C07D333/64 ,  A61K31/4535 ,  A61K31/567 ,  A61K45/06 ,  A61K2300/00

    摘要： The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimer's disease, prevention of breast cancer, and up-regulating ChAT.

    摘要翻译： 本发明涉及6-羟基-3-（4- [2-（哌啶-1-基）乙氧基]苯氧基）-2-（4-甲氧基苯基）苯并[b]噻吩盐酸盐的新型结晶水合物，其用途 包括抑制与雌激素剥夺有关的疾病状态，包括心血管疾病，高脂血症和骨质疏松症; 抑制子宫内膜异位症，子宫纤维化，雌激素依赖性癌症（包括乳腺癌和子宫癌），前列腺癌，良性前列腺增生症，包括阿尔茨海默病在内的CNS疾病，预防乳腺癌和上调ChAT等其他病理状况。